4.8 Review

Autophagy modulation as a potential therapeutic target for diverse diseases

Journal

NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 9, Pages 709-U84

Publisher

NATURE PORTFOLIO
DOI: 10.1038/nrd3802

Keywords

-

Funding

  1. Wellcome Trust
  2. Wellcome Trust/Medical Research Council
  3. UK Medical Research Council
  4. National Institute for Health Research Biomedical Research Unit in Dementia at Addenbrooke's Hospital, Cambridge, UK
  5. US National Institutes of Health (NIH) [RO1 CA109618, U54AI057156]
  6. INSERM
  7. Universite Paris-Sud
  8. Agence Nationale pour la Recherche
  9. Institut National du Cancer
  10. MRC [G0600194, MC_G1000734] Funding Source: UKRI
  11. Medical Research Council [G0600194, MC_G1000734] Funding Source: researchfish

Ask authors/readers for more resources

Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available